Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Teclistamab
Trade Name
Synonyms JNJ-64007957|BCMAxCD3
Drug Descriptions

Teclistamab (JNJ-64007957) is a bispecific antibody that targets CD3 and BCMA, potentially resulting in increased immune response against BCMA-expressing tumor cells (Blood Dec 2016, 128 (22) 5668).

CAS Registry Number 2119595-80-9
NCIT ID C136823


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Bortezomib + Daratumumab + Lenalidomide + Teclistamab Bortezomib Daratumumab Lenalidomide Teclistamab 0 1
Daratumumab + Pomalidomide + Teclistamab Daratumumab Pomalidomide Teclistamab 0 1
Daratumumab + Teclistamab Daratumumab Teclistamab 0 2
Nirogacestat + Teclistamab Nirogacestat Teclistamab 0 1
Talquetamab + Teclistamab Talquetamab Teclistamab 0 1
Teclistamab Teclistamab 0 2

Additional content available in CKB BOOST